Loading…

Religious coping and death depression in Iranian patients with cancer: relationships to disease stage

Purpose The study investigated relationships among the extent of disease, religious coping, and death depression in Iranian patients with cancer. Method A descriptive cross-sectional study was conducted with a convenience sample of 482 Iranian cancer patients. Participants completed demographic and...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2018-08, Vol.26 (8), p.2571-2579
Main Authors: Sharif, Saeed Pahlevan, Lehto, Rebecca H., Nia, Hamid Sharif, Goudarzian, Amir Hossein, Haghdoost, Ali Akbar, Yaghoobzadeh, Ameneh, Tahmasbi, Bahram, Nazari, Roghieh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The study investigated relationships among the extent of disease, religious coping, and death depression in Iranian patients with cancer. Method A descriptive cross-sectional study was conducted with a convenience sample of 482 Iranian cancer patients. Participants completed demographic and health, death depression, and religious coping surveys. Results After controlling for demographic and health characteristics, positive and negative religious coping behaviors were significantly related to the experience of death depression. There was an interaction effect between negative religious coping and extent of disease with significant positive relationships to the experience of death depression. Conclusions Negative religious coping was found to be more closely associated with death depression in patients with earlier stage disease than those with advanced stages of cancer in this sample of patients with cancer from Iran. Findings support assessing patients for use of religious coping strategies. Muslim patients who are religiously alienated and have existential anguish may be vulnerable and need heightened support following diagnosis and during treatment of early stage cancer.
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-018-4088-2